Merit Medical Systems | MMSI - Gross Profit On Sales


Merit Medical Systems reported $184.8M in Gross Profit on Sales for its fiscal quarter ending in March of 2026.





Gross Profit On Sales Change Date
3M USD 2.46B 398M Mar/2026
Abbott USD 5.86B 675M Mar/2026
AngioDynamics USD 44.78M 2.93M Sep/2025
Anika Therapeutics USD 19.18M 3.6M Dec/2025
AtriCure USD 109.31M 3.97M Mar/2026
Baxter International USD 891M 314M Mar/2026
Becton, Dickinson and Co. USD 2.15B 257M Mar/2026
Boston Scientific USD 3.61B 64M Mar/2026
Cooper Companies USD 735.4M 40.2M Mar/2026
Dexcom USD 750.3M 42.4M Mar/2026
Edwards Lifesciences USD 1.29B 59.4M Mar/2026
Globus Medical USD 496.26M 39.69M Mar/2026
Haemonetics USD 202.39M 7.64M Dec/2025
ICU Medical USD 202.98M 2.1M Dec/2025
Insulet USD 540.8M 27.8M Mar/2026
Integra LifeSciences USD 213.21M 3.89M Mar/2026
J&J USD 17.24B 642M Mar/2026
Medtronic USD 6.01B 595M Mar/2026
Merit Medical Systems USD 184.8M 10.56M Mar/2026
Olympus JPY 192.76B 27.86B Mar/2026
Pfizer USD 11.04B 1.24B Mar/2026
STAAR Surgical USD 43.74M 34.13M Dec/2025
Stryker USD 3.81B 675M Mar/2026
Surmodics USD 20.08M 31.62M Jun/2025
Tandem Diabetes Care USD 167.46M 33.17M Dec/2025
Teleflex USD 307.43M 21K Mar/2026
Terumo JPY 149.02B 4.17B Mar/2026
Zimmer Biomet Holdings USD 1.27B 8.1M Dec/2025